XOMA Royalty (XOMA) Other Non-Current Assets (2010 - 2026)
XOMA Royalty (XOMA) reported Other Non-Current Assets of $174000.0 for Q1 2026, down 94.81% on a YoY basis from $3.4 million in Q1 2025, and down 99.62% sequentially from $45.4 million in Q4 2025.
XOMA Royalty (XOMA) Other Non-Current Assets (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 17 years of Other Non-Current Assets data on file, last reported at $174000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 94.81% year-over-year to $174000.0; the trailing twelve-month figure through Mar 2026 stood at $174000.0 (down 94.81% YoY), and the FY2025 full-year result was $45.4 million, up 1221.71% from the prior year.
- Other Non-Current Assets declined to $174000.0 in Q1 2026, from $45.4 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $45.4 million in Q4 2025 to a low of $174000.0 in Q1 2026.
- A 5-year average of $6.6 million and a median of $533000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets jumped 2246.15% in 2023 and tumbled 94.81% in 2026, its largest moves.
- Tracing XOMA's Other Non-Current Assets over 5 years: stood at $260000.0 in 2022, then jumped by 2246.15% to $6.1 million in 2023, then sank by 43.74% to $3.4 million in 2024, then surged by 1221.71% to $45.4 million in 2025, then slumped by 99.62% to $174000.0 in 2026.
- Business Quant data shows XOMA's Other Non-Current Assets at $174000.0 in Q1 2026, $45.4 million in Q4 2025, and $38.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 174,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 174,000.00 |
| Dec 31, 2025 | 45.36 Mn |
| Sep 17, 2025 | 38.06 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 3.43 Mn |
| Sep 30, 2024 | 4.69 Mn |
| Jun 30, 2024 | 6.02 Mn |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 411,000.00 |
| Jun 30, 2023 | 283,000.00 |
| Mar 31, 2023 | 260,000.00 |
| Dec 31, 2022 | 260,000.00 |
| Sep 30, 2022 | 260,000.00 |
| Jun 30, 2022 | 260,000.00 |
| Mar 31, 2022 | 301,000.00 |
| Dec 31, 2021 | 301,000.00 |
| Sep 30, 2021 | 301,000.00 |
| Jun 30, 2021 | 128,000.00 |